OncRef

Clinical Trial: NCT04160910

5HTP Regulation Of Asthma In Children

Status:

RECRUITING

Phase:

Phase 2

Lead Sponsor:Indiana University
Information Provided By:Indiana University
Last Update Posted:2026-10-01

Study Overview

Brief Summary

The purpose of this study is to learn more about if taking a supplement called 5-hydroxytryptophan (5HTP) can improve breathing and anxiety symptoms related to asthma. To help learn more subjects will either be assigned to a group that is taking the supplement (5HTP) or a group that is taking a placebo. This will be decided randomly. Later in the study subjects will crossover to the other group.There are 5 study visits over the course of about 12 weeks.

Official Title

5HTP Regulation Of Asthma In Children

Conditions

Mild or Moderate Asthma With Allergic Sensitization

Intervention / Treatment

  • Drug: 5-Hydroxytryptophan
  • Drug: Placebo

Other Study ID Numbers

  • Kloepfer_1902366300

Start Date (Actual)

2021-02-11

Primary Completion Date (Estimated)

2026-12-31

Study Completion Date (Estimated)

2026-12-31

Enrollment (Estimated)

20

Study Type

Interventional

Phase

Phase 2